Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q3 2024 (September 30)5holders
$1.05avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings. The largest holders were Sei Investments Co. ($325K), Bank of New York Mellon Corp ($315K) and Oppenheimer Asset Management Inc. ($93K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $787K |
| Exits | 0 | $0 |
Ownership 5 holders
| Sei Investments Co. | 0.00% | New | 308,000 | $325K |
| Bank of New York Mellon Corp | 0.00% | New | 300,000 | $315K |
| Oppenheimer Asset Management Inc. | 0.00% | New | 88,000 | $93K |
| Stephens Inc. | 0.00% | New | 48,000 | $51K |
| Comerica Bank | 0.00% | New | 3,000 | $3K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.